Systematic Comparison of Peptidic Proteasome Inhibitors Highlights the α-Ketoamide Electrophile as an Auspicious Reversible Lead Motif

• Published in: Angewandte Chemie International Edition 2014-02, Vol.53 (6), p.1679-1683
• Main Authors: Stein, Martin L., Cui, Haissi, Beck, Philipp, Dubiella, Christian, Voss, Constantin, Krüger, Achim, Schmidt, Boris, Groll, Michael
• Format: Article
• Language: English
• Subjects: Binding Sites; Boronic Acids - chemistry; Boronic Acids - metabolism; Bortezomib; Catalytic Domain; cell biology; Crystallography, X-Ray; HeLa Cells; Humans; ketoamides; Leupeptins - chemistry; Leupeptins - metabolism; Molecular Dynamics Simulation; Oligopeptides - chemistry; Oligopeptides - metabolism; peptide electrophiles; Peptides - chemistry; Peptides - metabolism; Proteasome Endopeptidase Complex - chemistry; Proteasome Endopeptidase Complex - metabolism; Proteasome Inhibitors - chemistry; Proteasome Inhibitors - metabolism; proteasomes; Protein Binding; Pyrazines - chemistry; Pyrazines - metabolism; reversible inhibitors
• ISSN: 1433-7851; 1521-3773
• DOI: 10.1002/anie.201308984

The ubiquitin–proteasome system (UPS) has been successfully targeted by both academia and the pharmaceutical industry for oncological and immunological applications. Typical proteasome inhibitors are based on a peptidic backbone endowed with an electrophilic C‐terminus by which they react with the active proteolytic sites. Although the peptide moiety has attracted much attention in terms of subunit selectivity, the target specificity and biological stability of the compounds are largely determined by the reactive warheads. In this study, we have carried out a systematic investigation of described electrophiles by a combination of in vitro, in vivo, and structural methods in order to disclose the implications of altered functionality and chemical reactivity. Thereby, we were able to introduce and characterize the class of α‐ketoamides as the most potent reversible inhibitors with possible applications for the therapy of solid tumors as well as autoimmune disorders. A chemical leitmotif: Proteasome inhibitors featuring different electrophilic warheads were systematically compared. The results led to the introduction of the α‐ketoamide unit as a promising reversible lead structure. The properties of the corresponding compounds in vitro and in vivo are comparable with those of the commercially available anticancer drugs Velcade and Kyprolis.